EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 38 filers reported holding EDGE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $5,000 | -61.5% | 15,594 | 0.0% | 0.00% | – |
| Q3 2018 | $13,000 | -18.8% | 15,594 | 0.0% | 0.00% | – |
| Q2 2018 | $16,000 | -81.8% | 15,594 | -79.0% | 0.00% | – |
| Q1 2018 | $88,000 | -83.7% | 74,259 | +28.9% | 0.00% | – |
| Q4 2017 | $540,000 | -12.9% | 57,606 | -0.3% | 0.00% | – |
| Q3 2017 | $620,000 | +4.4% | 57,774 | -0.2% | 0.00% | – |
| Q2 2017 | $594,000 | +6.6% | 57,902 | -5.3% | 0.00% | – |
| Q1 2017 | $557,000 | -27.1% | 61,171 | +0.2% | 0.00% | – |
| Q4 2016 | $764,000 | +41.7% | 61,078 | +18.0% | 0.00% | – |
| Q3 2016 | $539,000 | +17.9% | 51,755 | +14.3% | 0.00% | – |
| Q2 2016 | $457,000 | +124.0% | 45,280 | +102.7% | 0.00% | – |
| Q1 2016 | $204,000 | -15.0% | 22,343 | +16.2% | 0.00% | – |
| Q4 2015 | $240,000 | – | 19,234 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,344,868 | $24,058,000 | 16.90% |
| VHCP Management II, LLC | 1,933,582 | $19,839,000 | 7.92% |
| ACUTA CAPITAL PARTNERS, LLC | 1,504,612 | $15,437,000 | 4.32% |
| Opaleye Management Inc. | 130,000 | $1,334,000 | 0.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,000 | $1,539,000 | 0.26% |
| DAFNA Capital Management LLC | 19,400 | $199,000 | 0.14% |
| REGENTATLANTIC CAPITAL LLC | 134,900 | $1,384,000 | 0.13% |
| MARK SHEPTOFF FINANCIAL PLANNING, LLC | 14,400 | $148,000 | 0.10% |
| TFS CAPITAL LLC | 20,080 | $206,000 | 0.08% |
| EAGLE ASSET MANAGEMENT INC | 901,359 | $9,247,000 | 0.06% |